Correspondence 0001213900-25-010385 from OS Therapies Inc (OSTX)
OS Therapies Inc
Date: Feb. 5, 2025 · CIK: 0001795091 · Accession: 0001213900-25-010385
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284631
Letter
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 5, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated (the “Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, February 4, 2025.
The Company is no longer requesting that such Registration Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally withdraw our request for acceleration of the effective date.
Thank you for your assistance.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
February 5, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
OS Therapies Incorporated hereby withdraws the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, February 4, 2025.
We are no longer requesting that such Registration Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
OS Therapies Incorporated
Show Raw Text
CORRESP
1
filename1.htm
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 5, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated (the “Company”),
this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence
via EDGAR on Tuesday, February 4, 2025.
The Company is no longer requesting that such Registration
Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally withdraw our request
for acceleration of the effective date.
Thank you for your assistance.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc:
Paul A. Romness, MPH
February 5, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
OS Therapies Incorporated hereby withdraws the
request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, February 4, 2025.
We are no longer requesting
that such Registration Statement be declared effective at 4:30 p.m., Eastern Time, on Thursday, February 6, 2025, and we hereby formally
withdraw our request for acceleration of the effective date.
Very truly yours,
OS Therapies Incorporated
By:
/s/ Paul A. Romness
Paul A. Romness
President and Chief Executive Officer